Targeting AML through DR4 with a novel variant of rhTRAIL.
Szegezdi E, Reis CR, van der Sloot AM, Natoni A, O'Reilly A, Reeve J, Cool RH, O'Dwyer M, Knapper S, Serrano L, Quax WJ, Samali A.
Szegezdi E, et al.
J Cell Mol Med. 2011 Oct;15(10):2216-31. doi: 10.1111/j.1582-4934.2010.01211.x.
J Cell Mol Med. 2011.
PMID: 21070598
Free PMC article.